• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Review Details Targeted Therapies for Brain AVMs

by
November 10, 2026
in Health
Reading Time: 2 mins read
0
Review Details Targeted Therapies for Brain AVMs

Review Details Targeted Therapies for Brain AVMs

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new mini review published in Acta Neurochirurgica examines the emerging landscape of targeted treatments for brain arteriovenous malformations, or bAVMs. Authored by Jessica Youngkyung Jung, Ivan Radovanovic, and Ann Bailey, the article provides a comprehensive summary of the pathophysiology behind these vascular anomalies and the preclinical and clinical evidence supporting molecularly targeted drug therapies. The review highlights a critical shift in understanding bAVMs as a distinct disease entity driven by somatic mutations, separate from familial syndromes such as hereditary hemorrhagic telangiectasia and capillary malformation-AVM syndromes.

Brain arteriovenous malformations are characterized as abnormal tangles of vessels that shunt pressurized arterial blood directly into low-pressure veins. This structural abnormality creates a fragile vascular network that is prone to rupture, posing significant risks of hemorrhage and subsequent morbidity for affected individuals. The review notes that the risks associated with current treatment options may equal or even exceed the risks posed by the natural history of the disease itself. This precarious balance underscores an urgent need for the development and implementation of molecularly targeted therapies that can address the underlying biological mechanisms without the high procedural risks of traditional interventions.

Recent years have seen a transition toward molecular profiling, which has outlined the specific role of various somatic mutations within endothelial cells. These mutations contribute to the constitutive activation of cellular proliferation and migration, key processes in the formation and maintenance of the malformation.

The authors summarize the critical role of combinatorial treatment strategies in managing bAVMs. This includes the integration of molecular profiling to guide treatment decisions, ensuring that therapies are matched to the specific genotype of the malformation.

The review also discusses the importance of molecular profiling in the broader context of bAVM management. The article serves as a resource for researchers and clinicians interested in the molecular mechanisms of bAVM formation and the potential of targeted drugs.

Published as an open access article, the review is intended to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI, although the version shared early is subject to further edits and will be replaced by the final Version of Record.

Subject of Research: Molecularly targeted treatments and pathophysiology of brain arteriovenous malformations

Article Title: Targeted treatments for brain arteriovenous malformations: a review

Article References: Jung, J. Y., Radovanovic, I., & Bailey, A. (2026). Targeted treatments for brain arteriovenous malformations: a review. Acta Neurochirurgica. https://doi.org/10.1007/s00701-026-07046-4

Image Credits: AI Generated

DOI: 10.1007/s00701-026-07046-4

Keywords: brain arteriovenous malformations, targeted therapy, molecular profiling, somatic mutations, neurovascular disease, Acta Neurochirurgica, genotype-driven care, endothelial cells, Targeted, treatments, brain, arteriovenous

News Source: Cassandra Pierce. (November 10, 2026). Review Details Targeted Therapies for Brain AVMs. Scienmag.

Tags: Acta NeurochirurgicaarteriovenousBrainbrain arteriovenous malformationsEndothelial Cellsgenotype-driven caremolecular profilingneurovascular diseasesomatic mutationsTargetedtargeted therapytreatments
Share12Tweet7Share2ShareShareShare1

Related Posts

Adjunctive rhBNP Linked to Favorable Cardiac Indices in Non-Randomized PCI Study

Adjunctive rhBNP Linked to Favorable Cardiac Indices in Non-Randomized PCI Study

November 19, 2026
FDA Approvals Reveal Antibacterial Rebound Masking Persistent Lack of Mechanistic Innovation

FDA Approvals Reveal Antibacterial Rebound Masking Persistent Lack of Mechanistic Innovation

November 19, 2026

Low-Virulence Bacteria Fail to Prove Causation in Spinal Disc Degeneration

November 19, 2026

Brain Potentials Fail to Reliably Track Opioid Analgesia During Anesthesia

November 19, 2026

POPULAR NEWS

  • Tryptophan Can Contribute to Seawater Iron Reduction at Lower pH

    Tryptophan Can Contribute to Seawater Iron Reduction at Lower pH

    29 shares
    Share 12 Tweet 7
  • Preserving Cervical Carotid Segments During Autopsy May Facilitate Subsequent Facial Embalming

    29 shares
    Share 12 Tweet 7
  • Adaptive Adversarial Network Boosts Seismic Fault Identification Accuracy Across Surveys

    29 shares
    Share 12 Tweet 7
  • Prenatal Testing Identifies Rare Mosaic Trisomy 14 in Early Severe Fetal Malformations

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cascaded Neural Networks Optimize Carbonate Reservoir Production Under Geomechanical Stress Limits

Adjunctive rhBNP Linked to Favorable Cardiac Indices in Non-Randomized PCI Study

FDA Approvals Reveal Antibacterial Rebound Masking Persistent Lack of Mechanistic Innovation

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.